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Abstract
Introduction: ‘Non-dippers’ are individuals without the anticipated nocturnal decrease in blood pressure. An increased incidence of tar-
get organ damage and a worse outcome in terms of cardiovascular events have been reported in this group of people. The pathogenesis 
of non-dipper hypertension is not clear at present. We aimed to investigate the effects of overt and subclinical hypothyroidism on the 
development of a non-dipper blood pressure pattern via 24-hour ambulatory blood pressure monitoring.
Material and methods: 109 normotensive patients with overt and subclinical hypothyroidism were evaluated, and 95 of these patients 
without reverse dipping and masked hypertension were included in the study. The control group consisted of 75 gender- and age-matched, 
normotensive, euthyroid healthy individuals.
Results: Median serum TSH levels were 7.61 and 1.59 mUmL in patient and control groups, respectively. The number of non-dippers ac-
cording to systolic, diastolic and mean blood pressure was significantly higher in the patients with hypothyroidism compared to the control 
group. In linear regression analysis, TSH had a negative effect on the night/day ratio of the systolic, diastolic and mean blood pressures.
Conclusion: Despite the fact that the effect of hypothyroidism on non-dipper blood pressure pattern is not known, the present study has 
revealed that elevated TSH levels are likely to increase the risk of non-dipping in normotensive patients with either overt or subclinical 
hypothyroidism. (Pol J Endocrinol 2012; 63 (2): 97–103)
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Streszczenie
Wstęp: U osób określanych jako non-dippers nie występuje fizjologiczne obniżenie ciśnienia tętniczego w godzinach nocnych. Jak wynika 
z doniesień, w tej grupie chorych częściej dochodzi do zmian narządowych i zdarzeń sercowo-naczyniowych. Patogenezy nadciśnienia 
tętniczego typu non-dipper dotychczas nie wyjaśniono. Celem autorów było zbadanie wpływu jawnej i subklinicznej niedoczynności 
tarczycy na rozwój profilu dobowej zmienności ciśnienia tętniczego typu non-dipper metodą całodobowego automatycznego pomiaru 
ciśnienia tętniczego.
Materiał i metody: Spośród 109 chorych z prawidłowym ciśnieniem i z jawną lub subkliniczną niedoczynnością tarczycy do analizy 
włączono 95 osób, u których nie występował nocny wzrost ciśnienia tętniczego (reverse dipping) ani utajone nadciśnienie tętnicze. Grupa 
kontrolna składała się z 75 zdrowych osób z prawidłowym ciśnieniem tętniczym i prawidłową czynnością tarczycy odpowiednio dobranych 
pod względem płci i wieku.
Wyniki: Mediany stężeń TSH w surowicy w grupach badanej i kontrolnej wynosiły odpowiednio 7,61 i 1,59 mUml. Liczba osób, u których 
nie występował nocny spadek wartości skurczowego, rozkurczowego i średniego ciśnienia tętniczego, był istotnie wyższy w grupie chorych 
z niedoczynnością tarczycy niż w grupie kontrolnej. W analizie regresji liniowej wykazano istnienie odwrotnej zależności między stężeniem 
TSH a stosunkiem między nocnymi i dziennymi wartościami ciśnienia skurczowego, rozkurczowego i średniego ciśnienia tętniczego.
Wnioski: Mimo że nie wiadomo, jaki jest mechanizm oddziaływania niedoczynności tarczycy na rozwój dobowego profilu ciśnienia 
tętniczego typu non-dipper, w niniejszym badaniu wykazano, że podwyższone stężenie TSH może zwiększać ryzyko wystąpienia takiego 
profilu ciśnienia tętniczego u osób z prawidłowym ciśnieniem tętniczym i jawną lub subkliniczną niedoczynnością tarczycy. (Endokrynol 
Pol 2012; 63 (2): 97–103)
Słowa kluczowe: niedoczynność tarczycy, nocny spadek ciśnienia tętniczego, profil typu non-dipper, automatyczny całodobowy pomiar ciśnienia 
tętniczego, TSH
Introduction
Overt and subclinical hypothyroidism is closely asso-
ciated with increased cardiovascular morbidity. This in-
crease has been attributed to accelerated atherosclerosis, 
along with changes in blood pressure [1–5]. However, 
the relation between thyroid stimulating hormone 
(TSH) and blood pressure remains unclear [6]. Some 
recent studies have suggested that the risk of hyperten-
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increases in TSH levels [7–9]. Sympathetic nervous sys-
tem activation, increased vascular resistance, increased 
arterial stiffness, and endothelial dysfunction, which are 
thought to occur in association with hypothyroidism, 
may lead to an impairment in the regulation of blood 
pressure [3, 5, 7]. Moreover, it is thought that high TSH 
levels in such patients may lead to an impairment of 
the circadian rhythm of blood pressure by means of the 
changes occurring in the vascular system [10].
Twenty-four hour ambulatory blood pressure 
monitoring (ABPM) is of great importance in identify-
ing night-time blood pressure changes. A decrease of 
less than 10% in night-time blood pressure compared 
to daytime blood pressure is defined as non-dipping. 
A non-dipping profile is closely associated with car-
diovascular morbidity and mortality, cerebrovascular 
accidents, and target organ damage, both in hyperten-
sive and normotensive subjects. Therefore, early iden-
tification of a non-dipping profile is of great importance 
[11–15]. However, the etiopathogenesis of non-dipping 
has yet to be fully defined [11–15]. A limited number 
of studies have shown that a non-dipping profile is 
commoner in hypertensive patients with increased 
TSH levels. An increased prevalence of non-dippers 
after short-term hypothyroidism has been reported in 
a group of normotensive patients with thyroid carci-
nomas [10, 16].
The present study aimed to investigate the effect of 
overt and subclinical hypothyroidism on the develop-
ment of a non-dipper blood pressure profile, via 24-hour 
blood pressure monitoring, in normotensive subjects.
Material and methods
109 normotensive patients, who had been diag-
nosed with overt and subclinical hypothyroidism 
(TSH ≥ 4.5 mUmL), in the Internal Medicine and Endo-
crinology outpatient units of Gazi University Hospital 
between December 2007 and June 2008 were screened, 
and those who met the eligibility criteria were enrolled. 
Individuals who had previously received or were cur-
rently receiving antihypertensives or hypothyroidism 
medication, medication with a potential to elevate blood 
pressure levels (e.g. prednisone), or who had clinical or 
laboratory evidence of other secondary causes of hyper-
tension, were excluded. Individuals with renal, hepatic 
(cirrhosis, elevated liver enzymes) dysfunction, cardiac 
insufficiency, infection and acute inflammatory states 
were also excluded, along with patients with reverse 
dipping and masked hypertension. Finally, 95 patients 
were eligible for the study.
The control group consisted of 75 gender- and 
age-matched, normotensive, euthyroid healthy in-
dividuals out of 83 cases, with reverse dipping and 
masked hypertension excluded as in the hypothy-
roid group. In order to rule out selection bias, those 
healthy individuals who gave informed consent to 
participate in our study and who were admitted to 
the internal medicine outpatient clinic over a two 
month period, were all included in the control group. 
The institutional review board approved the human 
research protocol.
Clinic blood pressure measurements
Clinic blood pressure (BP) of each participant was meas-
ured three times on the non-dominant arm using a mer-
cury sphygmomanometer with an appropriately-sized 
cuff. Systolic and diastolic blood pressure values were 
identified from the first and fifth phase of Korotkoff 
sounds. During the measurements, the participant 
remained seated with the arm comfortably placed at 
heart level. 
Ambulatory Blood Pressure Monitoring (ABPM)
All subjects underwent 24-hour ABPM on a normal 
working day. They were instructed to act and work 
normally. A Spacelabs 90217 ambulatory blood pres-
sure monitor was used. Each patient used an arm cuff 
of similar size to the one used for routine office BP 
measurement in the non-dominant arm. The device 
was programmed to measure BP every 15 minutes 
between 6 a.m. and 11 p.m., and every 30 minutes 
between 11 p.m. and 6 a.m. All subjects were advised 
to rest or sleep between 10 p.m. and 6 a.m. Shift 
workers, and patients who could not rest or sleep 
at night, were not included in the study. ‘Dippers’ 
were defined as individuals whose night-time blood 
pressures dropped by more than 10% compared to 
their daytime blood pressures [17]. Likewise, a pa-
tient whose night-time blood pressure dropped by 
less than 10% was defined as a ‘non-dipper ’ and 
one whose night-time blood pressure was greater 
than the daytime value was defined as a ‘reverse 
dipper ’. ‘White-coat hypertension’ was defined as 
office hypertension with ambulatory normotension 
and ‘masked hypertension’ was defined as office 
normotension and ambulatory hypertension [17–19]. 
The study was conducted according to the Helsinki 
Declaration and approved by the Ethics Committee 
of the Gazi University School of Medicine.
Clinical information and laboratory data
Clinical information including height, weight, medi-
cal history, current medications, laboratory data, 
and smoking history was recorded. Body weight 
was measured with the participants in light clothing 
without shoes. Body mass index (BMI) was calcu-
lated as weight in kg divided by height in m2. Serum 
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parameters analysed were creatinine, blood glucose, 
total cholesterol, low-density lipoprotein cholesterol 
(LDL-C), triglycerides, free T3 (FT3), free T4 (FT4) 
and TSH (normal range 0.35–4.5 mIUmL). Assays 
were performed centrally in the Laboratory of Gazi 
University Hospital.
Statistical analysis
Data was shown as mean ± SD or as percentages, 
where appropriate. Standard descriptive statistics, 
a two-tailed student’s t test and a chi-squared test 
were used where appropriate to compare character-
istics of the groups. Mann-Whitney U test was used 
for non-normally distributed variables. Univariate 
correlation was established by the Spearman’s cor-
relation coefficient. To assess the influence of tested 
parameters on BP night/day ratio as the dependent 
variable, multiple regression analysis was performed. 
All statistical calculations were performed using the 
Statistical Package for the Social Sciences (SPSS ver-
sion 13). A p value of 0.05 was considered as statisti-
cally significant.
Results
Comparisons of the anthropometric measurements, 
demographic information and biochemical analysis 
results of the hypothyroid patients and the control 
group are shown in Table I. Serum LDL-C, total 
cholesterol and TSH levels of hypothyroid patients 
were significantly higher, and serum fT3 (free T3) and 
fT4 (free T4) levels were significantly lower, than the 
control group (Table I).
The readings of clinic blood pressure and 24- 
-hour blood pressure of the participants are shown 
in Table II. Although all the patients were within 
the normotensive ranges, the clinic blood pressures 
of the hypothyroid patients were found to be sig-
nificantly lower than those of the individuals in the 
control group. According to the 24-hour ABPM, the 
dipping ratios (daytime to night-time variation) of 
the systolic, diastolic and mean blood pressures were 
significantly lower in the patient group compared to 
the control group.
The number of non-dippers according to systolic, 
diastolic and mean blood pressure was significantly 
higher in the patients with hypothyroidism compared 
to the control group (Figure 1). The correlation analy-
sis between TSH levels and the study parameters 
revealed a weak positive correlation between TSH 
levels and triglyceride and LDL-C levels (R = 0.303, 
p = 0.000 and R = 0.257, p = 0.001 respectively) (Ta-
ble III). The correlation analysis of ambulatory blood 
pressure measurements and the clinic blood pres-
sure measurements showed a negative correlation 
between TSH levels and clinic systolic and diastolic 
blood pressures as well as with 24-hour systolic, dias-
tolic and mean blood pressures (Table III). In addition, 
there was a weak negative correlation between TSH 
levels and the daytime/night-time variations of sys-
tolic, diastolic and mean blood pressures (R = –0.333, 
p = 0.001, R = –0.322, p = 0.001, and R = –0.344, 
p = 0.001 respectively) (Table III). In linear regression 
analysis evaluating the independent effect of TSH on 
the night/day ratios, TSH had a negative effect on 
the night/day ratio of the systolic and diastolic blood 
Table I. Demographic and laboratory parameters of hypothyroid patients and control group
Tabela I. Dane demograficzne i parametry laboratoryjne u chorych z niedoczynnością tarczycy i w grupie kontrolnej
Hypothyroid patients (n = 95) Control group (n = 75) p
Gender (F/M) 85/10 62/13 0.144
Age (years) 39.78 ± 11.67 39.00 ± 12.25 0.710
BMI [kg/m2] 27.02 ± 4.50 26.13 ± 4.41 0.203
Smoking (Y/N) 36/59 25/50 0.325
TSH 18.16 ± 26.10 1.77 ± 0.99 0.000
FT3 2.35 ± 0.57 2.63 ± 0.42 0.011
FT4 0.90 ± 0.25 1.11 ± 0.33 0.000
FBG [mg/dL] 88.47 ± 9.59 89.44 ± 8.36 0.542
Cr 0.82 ± 0.14 0.79 ± 0.13 0.172
TG 143.04 ± 74.56 112.23 ± 54.97 0.002
LDL 134.25 ± 46.05 115.12 ± 33.33 0.003














Hypothyroidism and non-dipper blood pressure   Salih Inal et al.
pressures, when the night/day ratio was considered 
as the dependent variable, and age, BMI, LDL-C and 
TSH were considered as the independent variables 
Table II. Clinical and 24-hour ambulatory blood pressure recordings of hypothyroid patients and control group
Tabela II. Zapisy całodobowego automatycznego pomiaru ciśnienia tętniczego u chorych z niedoczynnością tarczycy i w grupie 
kontrolnej
Hypothyroid patients (mean ± SD) Control group (mean ± SD) p
Clinic SBP 116.79 ± 9.56 121.60 ± 8.42 0.002
Clinic DBP 74.63 ± 6.15 77.60 ± 5.15 0.001
24-hour SBP 110.04 ± 8.25 111.79 ± 6.87 0.109
24-hour DBP 69.47 ± 6.73 70.21 ± 5.53 0.345
24-hour MAP 83.73 ± 6.49 84.41 ± 5.51 0.443
Daytime SBP 111.93 ± 13.53 114.87 ± 14.29 0.013
Daytime DBP 72.33 ± 7.05 74.39 ± 5.87 0.031
Daytime MAP 86.39 ± 6.81 88.47 ± 5.98 0.042
Night-time MAP 104.42 ± 8.74 104.31 ± 13.03 0.474
Night-time DBP 64.03 ± 7.28 62.43 ± 6.20 0.132
Night-time MAP 78.45 ± 6.82 76.59 ± 5.96 0.057
SBP night/day ratio 7.52 ± 4.64 11.09 ± 4.60 0.000
DBP night/day ratio 11.38 ± 6.24 16.00 ± 6.21 0.000
MAP night/day ratio 9.12 ± 5.21 13.38 ± 5.29 0.000
SD — standard deviation; SBP — systolic blood pressure; DBP — diastolic blood pressure; MAP — mean arterial pressure
Figure 1. Percentages of non-dippers in the patients with hypothyroidism 
and the control group c2 test revealed significant differences between the 
groups in terms of number of dippers (p = 0.000, p = 0.001, and p = 
= 0.000, respectively); MAP — mean arterial pressure
Rycina 1. Odsetek osób z profilem typu non-dipper w grupie 
chorych z niedoczynnością tarczycy i w grupie kontrolnej; w teście c2 
wykazano istotne różnice między grupami pod względem liczby osób 
z fizjologicznym nocnym spadkiem ciśnienia tętniczego (odpowiednio 
p = 0,000; p = 0,001; p = 0,000); MAP — średnie ciśnienie tętnicze
(b = –0.152, p = 0.04; b = –0.158, p = 0.03; b = –0.176, 
p = 0.02, respectively) (Figure 2).
Discussion
In the present study, the number of non-dippers was 
found to be significantly higher in the group involving 
patients with overt and subclinical hypothyroidism 
compared to healthy euthyroid individuals. And the 
night/day ratios of blood pressure measurements were 
significantly lower in the patient group compared to 
the control group.
Non-dipping profile is important in assessing the 
cardiovascular prognosis and in determining target or-
gan damage at early stages [11–15]. However, the mech-
anism of the development of non-dipping remains un-
known [11–15]. The imbalance between the sympathetic 
and parasympathetic nervous systems may be the major 
effective mechanism. A decrease in the parasympathetic 
activity and an increase in the sympathetic activity are 
observed all night long in non-dipping patients [15]. 
Besides, various hormones (catecholamines, renin, 
aldosterone and cortisol) are thought to be effective in 
the development of a non-dipper profile [20]. It has been 
suggested, in the limited number of recent studies, that 
TSH is also likely to be among these hormones [7, 10, 
16, 20]. However, conflicting results have been obtained 
from these studies [7, 10, 16]. A TSH-mediated increase 
in vascular resistance, endothelial dysfunction, and 
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increased sympathetic nervous system sensitivity, may 
play a role in this probable association [3, 21–24]. Accord-
ingly, high noradrenalin levels and decreased number 
of vascular beta-adrenergic receptors may prevent the 
night-time decrease in blood pressure [15]. Moreover, 
endothelial dysfunction concurrent with TSH elevation 
via a decrease in vascular relaxation may be effective 
in the development of non-dipping [25]. The relation 
between TSH and renal sodium uptake might be an-
other mechanism considered for the development of 
Table III. Correlation between TSH levels and study parameters or clinic and 24-hour ambulatory blood pressure readings
Tabela III. Korelacja między stężeniami TSH i innymi parametrami analizowanymi w badaniu a wynikami całodobowego 
automatycznego pomiaru ciśnienia tętniczego
Blood pressure Study parameters
R p R p
Clinical SBP –0.249 0.001 FT3 –0.398 0.000
Clinical DBP –0.261 0.001 FT4 –0.555 0.000
24-hour DBP –0.073 0.344 Age 0.169 0.102
24-hour SBP –0.114 0.138 BMI 0.150 0.051
24-hour MAP –0.067 0.386 FBG –0.053 0.490
Night-time SBP 0.068 0.381 Creatinine 0.142 0.065
Night-time DBP 0.110 0.155 LDL-C 0.257 0.001
Night-time MAP 0.133 0.084 TG 0.303 0.000
Daytime SBP –0.178 0.020
Daytime DBP –0.156 0.042
Daytime MAP –0.154 0.045
DBP night/day ratio –0.322 0.000
SBP night/day ratio –0.333 0.000
MAP night/day ratio –0.344 0.000
SBP — systolic blood pressure; DBP — diastolic blood pressure; MAP — mean arterial pressure; FT3 — free T3; FT4 — free T4; BMI — body mass 
index; FBG — fasting blood glucose; LDL-C — low-density lipoprotein cholesterol; TG — triglyceride
Figure 2. Relation between TSH levels and dipping ratios of systolic and diastolic blood pressure; TSH — thyroid stimulating hormone; 
DBP — diastolic blood pressure; SBP — systolic blood pressure
Rycina 2. Zależności między stężeniami TSH i częstością nocnych spadków ciśnienia skurczowego i rozkurczowego; TSH — hormon 
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a non-dipping profile in patients with hypothyroidism. 
According to this mechanism, renal sodium uptake that 
increases with the increase in TSH levels may play a role 
in the development of a non-dipping profile, because 
previous studies have shown that serum Na+ levels are 
higher in non-dipper patients compared to dippers, and 
that a non-dipping profile is observed more commonly 
in Na+-sensitive hypertensives [22, 26].
Moreover, a weak but significant negative correla-
tion was found between TSH levels and the night/day 
ratio of blood pressure. This indicates that elevated 
TSH levels are likely to increase the risk of non-dip-
ping. At the very least, we can state that a non-dipping 
pattern is more prevalent in hypothyroid patients. Fur-
thermore, the independent effect of TSH on night/day 
ratios, as shown in linear regression analysis, cor-
roborates the hypothesis of increased non-dipping 
with elevated TSH levels. In the limited studies on 
this subject in the literature, it has been suggested that 
TSH elevation and non-dipping occur simultaneously 
in hypertensive patients [10]. An important element of 
our present study is the involvement of normotensive 
patients predominantly with subclinical hypothy-
roidism, because the necessity for cardiovascular risk 
assessment and treatment in subjects with subclinical 
hypothyroidism is still a matter of debate. Precise 
estimation of cardiovascular risk classification in such 
patients may help make accurate decisions for both the 
follow-up and treatment. In normotensive patients, 
a recent study about the association between TSH and 
dipping pattern was conducted by Botella-Carretero 
et al. [16]. It showed that short term hypothyroidism 
resulted in an increase in night-time systolic, mean 
and diastolic blood pressure, and was accompanied 
by an increase in the proportion of non-dippers in 
normotensive patients with differentiated thyroid 
carcinoma compared to euthyroid patients [16]. These 
outcomes parallel our findings.
The other finding of our study was the negative cor-
relation between TSH levels and clinic blood pressure 
and daytime ABPM measurements. Moreover, these 
measurements were observed to be significantly lower 
in the hypothyroid patients compared to the control 
group, suggesting that elevated TSH levels might 
lead to a decrease in daytime blood pressures. We at-
tributed this result to the close relation between TSH 
and the sympathetic and parasympathetic nervous 
systems. Elevated TSH levels activate the sympathetic 
nervous system while inhibiting the parasympathetic 
nervous system [15]. Long term activation of the sympa-
thetic nervous system may further result in insensitivity 
against sympathetic nervous system stimulations. Such 
insensitivity may lead to the relatively low activation of 
the sympathetic nervous system during daytime and 
high activation during night-time, and consequently 
to low blood pressures during the day and high blood 
pressures during the night. The decreased variation 
between daytime and night-time blood pressures via 
TSH effect may result in non-dipping. In an ABPM 
study conducted by Kotsis et al., a negative correlation 
was found between TSH and the mean systolic and 
diastolic blood pressures [7]. However, quite different 
results have been obtained from studies performed on 
the relation between TSH and blood pressure [6–9, 16]. 
While it has been suggested in some of the studies that 
there may be an increase in blood pressure levels by TSH 
level elevation, others have suggested just the opposite. 
These differing results may be due to variability in the 
study population characteristics as well as TSH levels, 
comorbidities, and the determination of blood pressure 
using methods other than ABPM [6–9].
The other finding of this present study was the 
significant positive correlation of TSH levels with 
cholesterol and triglyceride. There are studies in the 
literature suggesting that subclinical hypothyroidism, 
as well as overt hypothyroidism, leads to dyslipidaemia 
[1, 27]. Such negative effects on the lipid profile may 
play a role in the development of accelerated athero-
sclerosis in patients with hypothyroidism.
Our study has several limitations. First, the sample 
size was rather small; it would need to be larger to be 
of convincing statistical significance. Second, the sub-
jects in the control group were selected from a clinical 
practice and not from the general population. Third, 
the results of the correlation and regression analysis 
in our study are weak. They only mean an association 
between TSH and non-dipping, not a causative effect.
Conclusion
This study has revealed that elevated TSH levels are 
likely to increase the risk of non-dipping in normotensive 
patients with either overt or subclinical hypothyroid-
ism. In other words, we have found that a non-dipping 
blood pressure pattern is more prevalent in mild or overt 
hypothyroid patients. Moreover, it has been determined 
that elevated TSH levels seem to be associated with a de-
crease in daytime blood pressure measurements, even 
though the mechanism is not completely defined. These 
outcomes suggest that a non-dipping profile, which is 
associated with cardiovascular morbidity, may present as 
an additional risk factor in patients with hypothyroidism. 
Accordingly, ABPM measurements should be consid-
ered in hypothyroid patients to assess the risk factors, 
even if they are normotensive. Besides, in setting the 
indications of thyroid hormone replacement therapy 
in subclinical hypothyroidism, evaluating the dipping 
pattern via ABPM would play a role in the accurate 
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estimation of cardiovascular risk factors, even in patients 
who are clinically normotensive. Further studies are 
warranted to confirm this association, and to find out 
the probable mechanisms of this association.
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